BR9916491A - 4-(aminometil)-piperidina benzamidas para tratamento de distúrbios gastrintestinais - Google Patents
4-(aminometil)-piperidina benzamidas para tratamento de distúrbios gastrintestinaisInfo
- Publication number
- BR9916491A BR9916491A BR9916491-4A BR9916491A BR9916491A BR 9916491 A BR9916491 A BR 9916491A BR 9916491 A BR9916491 A BR 9916491A BR 9916491 A BR9916491 A BR 9916491A
- Authority
- BR
- Brazil
- Prior art keywords
- hydrogen
- alkyl
- cycloalkyl
- alk
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Patente de Invenção: <B>"4-(AMINOMETIL)-PIPERIDINA BENZAMIDAS PARA TRATAMENTO DE DISTúRBIOS GASTRINTESTINAIS"<D>. A presente invenção de compostos de fórmula (I), uma forma estereoquimicamente isomérica dos mesmos, uma forma de N-óxido do mesmo ou um sal de adição de ácido do mesmo farmaceuticamente dos mesmos, -R^ 1^ - R^ 2^- é um radical bivalente de fórmula em que nos ditos radicais bivalentes um ou dois átomos de hidrogênio podem ser substituídos por C~ 1-6~ alquila ou hidróxi; R^ 3^ é hidrogênio ou halo; R^ 4^ é hidrogênio ou C~ 1-6~ alquila; R^ 5^ é hidrogênio ou C~ 1-6~ alquila; L é C~ 3-6~ cicloalquila, oxo C~ 5-6~ cicloalquila, C~ 2-6~ alquenila ou L é um radical de fórmula -Alk-R^ 6^, -Alk-X-R^ 7^, -Alk-Y-C(=O)-R^ 9^ ou -Alk-Y-C(=O)-NR^ 11^R^ 12^ em que cada Alk é C~ 1-12~ alcanodiíla; e R^ 6^ é hidrogênio, amino, ciano, C~ 1-6~ alquilsulfonilamino, C~ 3-6~ cicloalquila, oxo C~ 5-6~ cicloalquila, arila ou um sistema de anel heterocíclico; R^ 7^ é hidrogênio, C~ 1-6 alquila, hidróxi C~ 1-6~ alquil, C~ 3-6~ cicloalquila, arila ou um sistema de anel heterocíclico; X é O, S, SO~ 2~ ou NR^ 8^; o dito R^ 8^ sendo hidrogênio ou C~ 1-6~ alquila; R^ 9^ é hidrogênio, C~ 1-6~ alquila, C~ 3-6~ cicloalquila, C~ 1-6~ alquilóxi, hidróxi ou arila; Y é uma ligação direta ou NR^ 10^, o dito R^ 10^ sendo hidrogênio ou C~ 1-6~ alquila; R^ 11^ e R^ 12^ cada um independentemente são hidrogênio, C~ 1-6~ alquila, C~ 3-6~ cicloalquila, ou R^ 11^ e R^ 12^ combinados com o átomo de nitrogênio podem formar um anel pirrolidinila, piperidinila, piperazinila ou 4-morfolinila substituídas. São descritos processos para a preparação dos ditos produtos, formulações que compreendem os ditos produtos e uso dos mesmos como um remédio, em particular para tratar ou prevenir distúrbios gastrintestinais.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98204411 | 1998-12-22 | ||
PCT/EP1999/010064 WO2000037461A1 (en) | 1998-12-22 | 1999-12-14 | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9916491A true BR9916491A (pt) | 2001-09-04 |
Family
ID=8234539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9916491-4A BR9916491A (pt) | 1998-12-22 | 1999-12-14 | 4-(aminometil)-piperidina benzamidas para tratamento de distúrbios gastrintestinais |
Country Status (34)
Country | Link |
---|---|
US (2) | US6544997B1 (pt) |
EP (1) | EP1140915B1 (pt) |
JP (1) | JP4615725B2 (pt) |
KR (1) | KR100633680B1 (pt) |
CN (1) | CN1150190C (pt) |
AR (1) | AR024240A1 (pt) |
AT (1) | ATE297917T1 (pt) |
AU (1) | AU770397B2 (pt) |
BG (1) | BG64953B1 (pt) |
BR (1) | BR9916491A (pt) |
CA (1) | CA2355857C (pt) |
CZ (1) | CZ300851B6 (pt) |
DE (1) | DE69925865T2 (pt) |
DK (1) | DK1140915T3 (pt) |
EA (1) | EA003608B1 (pt) |
EE (1) | EE200100335A (pt) |
ES (1) | ES2245131T3 (pt) |
HK (1) | HK1039114B (pt) |
HR (1) | HRP20010445A2 (pt) |
HU (1) | HUP0104838A3 (pt) |
ID (1) | ID28953A (pt) |
IL (1) | IL143858A (pt) |
MY (1) | MY121852A (pt) |
NO (1) | NO321324B1 (pt) |
NZ (1) | NZ512871A (pt) |
PL (1) | PL197409B1 (pt) |
PT (1) | PT1140915E (pt) |
SI (1) | SI1140915T1 (pt) |
SK (1) | SK285829B6 (pt) |
TR (1) | TR200101962T2 (pt) |
TW (1) | TW570920B (pt) |
UA (1) | UA71591C2 (pt) |
WO (1) | WO2000037461A1 (pt) |
ZA (1) | ZA200105135B (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1547593A4 (en) * | 2002-09-12 | 2009-12-23 | Nagase Chemtex Corp | MEDICINAL COMPOSITION |
EA009464B1 (ru) * | 2003-06-19 | 2007-12-28 | Янссен Фармацевтика Н.В. | Бензамиды 4-(аминометил)пиперидина, замещённого гидроксикарбонилфенилом, в качестве антагонистов 5нт-рецепторов |
EP2305254A1 (en) | 2003-06-19 | 2011-04-06 | Janssen Pharmaceutica NV | Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists for the treatment of gatrointestinal conditions |
EP1638961B1 (en) * | 2003-06-19 | 2009-11-18 | Janssen Pharmaceutica N.V. | Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
PT1638959E (pt) * | 2003-06-19 | 2007-12-12 | Janssen Pharmaceutica Nv | 4-(aminometil)piperidinobenzamidas antagonistas de 5ht4 |
JO2478B1 (en) * | 2003-06-19 | 2009-01-20 | جانسين فارماسوتيكا ان. في. | (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists |
AP2184A (en) * | 2003-09-03 | 2010-12-02 | Pfizer | Benzimidazolone compounds having 5-HT4 receptor agonistic activity. |
US7964727B2 (en) * | 2003-11-24 | 2011-06-21 | Pfizer Inc. | Quinolonecarboxylic acid compounds having 5-HT4 receptor agonistic activity |
TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
TWI351282B (en) * | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
EP1758891A2 (en) | 2004-06-15 | 2007-03-07 | Pfizer Japan Inc. | Benzimidazolone carboxylic acid derivatives |
US20060035890A1 (en) * | 2004-08-10 | 2006-02-16 | Amit Banerjee | Compounds and methods for the treatment of ubiquitin conjugating disorders |
JP5042028B2 (ja) * | 2004-11-05 | 2012-10-03 | セラヴァンス, インコーポレーテッド | キノリノン−カルボキサミド化合物 |
JP5086091B2 (ja) * | 2004-11-05 | 2012-11-28 | セラヴァンス, インコーポレーテッド | 5−ht4受容体アゴニスト化合物 |
JP5159317B2 (ja) * | 2004-12-22 | 2013-03-06 | セラヴァンス, インコーポレーテッド | インダゾール−カルボキサミド化合物 |
WO2006094063A1 (en) * | 2005-03-02 | 2006-09-08 | Theravance, Inc. | Quinolinone compounds as 5-ht4 receptor agonists |
US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
US8377968B2 (en) | 2008-06-02 | 2013-02-19 | Zalicus Pharmaceuticals, Ltd. | N-piperidinyl acetamide derivatives as calcium channel blockers |
US10208023B2 (en) | 2013-03-01 | 2019-02-19 | Mark G. DeGiacomo | Heterocyclic inhibitors of the sodium channel |
US20180305334A1 (en) * | 2015-10-14 | 2018-10-25 | Aquinnah Pharmaceuticals, Inc. | Compounds, compositions and methods of use against stress granules |
US20220241258A1 (en) | 2019-07-11 | 2022-08-04 | Praxis Precision Medicines, Inc. | Formulations of t-type calcium channel modulators and methods of use thereof |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ225152A (en) * | 1987-07-17 | 1990-04-26 | Janssen Pharmaceutica Nv | Heterocyclically substituted piperidinyl benzamides as pharmaceuticals |
CA1317940C (en) * | 1987-09-25 | 1993-05-18 | Georges H. P. Van Daele | Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
US5374637A (en) * | 1989-03-22 | 1994-12-20 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
NZ243993A (en) | 1991-08-20 | 1994-10-26 | Smithkline Beecham Plc | Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity |
JP3294611B2 (ja) * | 1991-09-12 | 2002-06-24 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5−ht4レセプター・アンタゴニスト |
CA2105072C (en) * | 1992-01-23 | 1998-07-28 | Hiroshi Nagase | Morphinan derivative and its pharmaceutical applications |
AU667874B2 (en) * | 1992-02-06 | 1996-04-18 | Smithkline Beecham Plc | Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists |
GB9219163D0 (en) | 1992-09-10 | 1992-10-28 | Smithkline Beecham Plc | Pharmaceuticals |
MX9306311A (es) | 1992-10-13 | 1994-04-29 | Smithkline Beecham Plc | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen |
AU5150393A (en) | 1992-10-13 | 1994-05-09 | Smithkline Beecham Plc | Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists |
NZ257545A (en) | 1992-11-05 | 1997-01-29 | Smithkline Beecham Plc | Heterocyclic (especially piperidine) derivatives and pharmaceutical compositions |
GB9301660D0 (en) * | 1993-01-28 | 1993-03-17 | Smithkline Beecham Plc | Pharmaceuticals |
GB9312348D0 (en) | 1993-06-16 | 1993-07-28 | Smithkline Beecham Plc | Pharmaceuticals |
ES2103675B1 (es) * | 1995-01-10 | 1998-07-01 | Almirall Lab | Nuevas piperidinas sustituidas. |
IT1275903B1 (it) | 1995-03-14 | 1997-10-24 | Boehringer Ingelheim Italia | Esteri e ammidi della 1,4-piperidina disostituita |
GB9507882D0 (en) | 1995-04-18 | 1995-05-31 | Pharmacia Spa | Substituted dihydrobenzofuran derivatives as 5-ht4 agonists |
ATE250931T1 (de) * | 1996-02-15 | 2003-10-15 | Janssen Pharmaceutica Nv | Verwendung von 5-ht4 antagonisten zur überwindung der gastrointestinalen beschädigung, die durch inhibitoren der serotonin-wiederaufnahme hervorgerufen werden |
TW445263B (en) * | 1996-02-29 | 2001-07-11 | Janssen Pharmaceutica Nv | Novel esters of 1,4-disubstituted piperidine derivatives |
TW402591B (en) * | 1997-07-11 | 2000-08-21 | Janssen Pharmaceutica Nv | Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
DE69935600T2 (de) * | 1998-09-10 | 2007-12-06 | F. Hoffmann-La Roche Ag | Dihydrobenzodioxincarbonsäureamid- und ketonderivate als 5-ht4-rezeptorantagonisten |
DE10217868A1 (de) * | 2002-04-22 | 2003-10-30 | Jomed N V | Ballon-Katheter |
-
1999
- 1999-12-03 TW TW088121125A patent/TW570920B/zh not_active IP Right Cessation
- 1999-12-14 BR BR9916491-4A patent/BR9916491A/pt not_active Application Discontinuation
- 1999-12-14 US US09/857,905 patent/US6544997B1/en not_active Expired - Lifetime
- 1999-12-14 EA EA200100710A patent/EA003608B1/ru not_active IP Right Cessation
- 1999-12-14 EE EEP200100335A patent/EE200100335A/xx unknown
- 1999-12-14 CZ CZ20012117A patent/CZ300851B6/cs not_active IP Right Cessation
- 1999-12-14 ES ES99967956T patent/ES2245131T3/es not_active Expired - Lifetime
- 1999-12-14 JP JP2000589532A patent/JP4615725B2/ja not_active Expired - Fee Related
- 1999-12-14 DE DE69925865T patent/DE69925865T2/de not_active Expired - Lifetime
- 1999-12-14 KR KR1020017005055A patent/KR100633680B1/ko not_active IP Right Cessation
- 1999-12-14 ID IDW00200101336A patent/ID28953A/id unknown
- 1999-12-14 CA CA002355857A patent/CA2355857C/en not_active Expired - Fee Related
- 1999-12-14 AU AU24328/00A patent/AU770397B2/en not_active Ceased
- 1999-12-14 PL PL348417A patent/PL197409B1/pl unknown
- 1999-12-14 HU HU0104838A patent/HUP0104838A3/hu unknown
- 1999-12-14 WO PCT/EP1999/010064 patent/WO2000037461A1/en active IP Right Grant
- 1999-12-14 PT PT99967956T patent/PT1140915E/pt unknown
- 1999-12-14 SI SI9930822T patent/SI1140915T1/sl unknown
- 1999-12-14 UA UA2001064399A patent/UA71591C2/uk unknown
- 1999-12-14 NZ NZ512871A patent/NZ512871A/xx unknown
- 1999-12-14 SK SK859-2001A patent/SK285829B6/sk not_active IP Right Cessation
- 1999-12-14 AT AT99967956T patent/ATE297917T1/de not_active IP Right Cessation
- 1999-12-14 IL IL14385899A patent/IL143858A/xx not_active IP Right Cessation
- 1999-12-14 TR TR2001/01962T patent/TR200101962T2/xx unknown
- 1999-12-14 CN CNB998147699A patent/CN1150190C/zh not_active Expired - Fee Related
- 1999-12-14 DK DK99967956T patent/DK1140915T3/da active
- 1999-12-14 EP EP99967956A patent/EP1140915B1/en not_active Expired - Lifetime
- 1999-12-17 MY MYPI99005534A patent/MY121852A/en unknown
- 1999-12-21 AR ARP990106644A patent/AR024240A1/es active IP Right Grant
-
2001
- 2001-06-07 BG BG105571A patent/BG64953B1/bg unknown
- 2001-06-08 NO NO20012858A patent/NO321324B1/no not_active IP Right Cessation
- 2001-06-14 HR HR20010445A patent/HRP20010445A2/hr not_active Application Discontinuation
- 2001-06-21 ZA ZA200105135A patent/ZA200105135B/en unknown
-
2002
- 2002-01-29 HK HK02100161.1A patent/HK1039114B/zh not_active IP Right Cessation
-
2003
- 2003-01-29 US US10/353,307 patent/US7205410B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9916491A (pt) | 4-(aminometil)-piperidina benzamidas para tratamento de distúrbios gastrintestinais | |
BRPI9811688A (pt) | benzamidas bicíclicas gastrocinéticas de derivados de piperidina 3- ou 4- substituídos com 4-aminometil), processo para preparação das mesmas, composições farmacêuticas compreendendo as mesmas e processo para preparação das referidas composições. | |
JP4680774B2 (ja) | アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体 | |
TR199900255T2 (xx) | Muskarinik antagonistleri | |
BR0213455A (pt) | Composto, seu uso, composição farmacêutica, método para o tratamento ou prevenção de uma doença para a qual um receptor adenosina está relacionado, e método para promover a defecação | |
BR0311806A (pt) | Derivados heteroaril benzocondensado-amida de tienopiridinas úteis como agentes terapêuticos, composições farmacêuticas que os incluem e métodos para o seu uso | |
BR112019011801A2 (pt) | composto, composição farmacêutica e método de inibição de dlk, método de tratamento de uma doença mediada por dlk, método de tratamento de câncer e redução do desenvolvimento de um distúrbio neurológico induzido por quimioterapia e método para alcançar um efeito em um paciente | |
ATE411985T1 (de) | Substituierte piperazine als modulatoren des melanocortinrezeptors | |
TW200635903A (en) | Therapeutic agents | |
TW200505453A (en) | Non-nucleoside reverse transcriptase inhibitors | |
BRPI0408767B8 (pt) | inlbidores da transcriptase reversa não-nucleosídeos para tratamento de doenças mediadas pelo hiv, seu uso, e composição farmacêutica | |
AR041545A1 (es) | Derivados sustituidos de 1,4-di-piperidin-4 il-piperazina y su uso como antagonistas de neuroquininas | |
TW200633986A (en) | Therapeutic agents | |
ATE425142T1 (de) | Inhibitoren von c-jun n-terminal kinasen (jnk) | |
KR20180035919A (ko) | Irak4억제제 및 이의 용도 | |
BG108180A (en) | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
MXPA03008635A (es) | Compuestos de dihidropirimidina ciano sustituidos y su uso para tratar enfermedades. | |
BRPI0518117A (pt) | uso de um derivado de piridotienopirimidina, composição farmacêutica, método para o tratamento de um sujeito que sofre de uma condição patológica ou doença susceptìvel de cura pela inibição da fosfodiesterase 4 e produto de combinação | |
TW200509933A (en) | Therapeutic agents | |
AR057461A1 (es) | Derivados de pirazol, proceso de preparacion, composiciones farmaceuticas y usos | |
BR0111859A (pt) | Compostos para tratamento de relaxamento prejudicado do fundo gástrico | |
AR024146A1 (es) | Derivados de 4-fenil-pirimidina | |
MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
BR0211030A (pt) | Derivado de pirrolidina oxadiazole, uso de um derivado de pirrolidina oxadiazole, composição farmacêutica contendo pelo menos um derivado de pirrolidina oxadiazole, método para preparação de um composto de pirrolidina oxadiazole | |
BRPI0016638B8 (pt) | compostos análogos de homopiperidilbenzimidazóis substituídos como relaxantes fúndicos, processo para preparar os mesmos, composição farmacêutica e processo para prepará-la. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |